Literature DB >> 17059184

Carbonic anhydrase inhibitors. N-cyanomethylsulfonamides--a new zinc binding group in the design of inhibitors targeting cytosolic and membrane-anchored isoforms.

Jean-Yves Winum1, Alessandro Cecchi, Achour Seridi, Andrea Scozzafava, Jean-Louis Montero, Claudiu T Supuran.   

Abstract

A series of N-cyanomethyl aromatic sulfonamides and bis-sulfonamides was prepared by reaction of arylsulfonyl halides with aminoacetonitrile. The obtained derivatives incorporated various aryl moieties, such as 4-halogeno/alkyl/aryl/nitro-substituted-phenyl, pentafluorophenyl or 2-naphthyl. Moderate inhibitory activity was detected for some compounds against the cytosolic human isoform II of the metalloenzyme carbonic anhydrase (CA, EC 4.2.1.1), hCA II, with inhibition constants of 90, 180 and 560n M for the 4-nitrophenyl-, 4-iodophenyl- and pentafluorophenyl-N-cyanomethylsulfonamides, respectively. Other derivatives acted as weak inhibitors of isoforms hCA I (KIs of 720 nM-45 microM), hCA II (KIs of 1000-9800 nM) and hCA IX (KIs of 900-10200 nM). Thus, the N-cyanomethylsulfonamide zinc binding group is less effective than the sulfonamide, sulfamate or sulfamide ones for the design of effective CA inhibitors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17059184     DOI: 10.1080/14756360600642370

Source DB:  PubMed          Journal:  J Enzyme Inhib Med Chem        ISSN: 1475-6366            Impact factor:   5.051


  2 in total

1.  Quantitative Characterization of Three Carbonic Anhydrase Inhibitors by LESA Mass Spectrometry.

Authors:  Eva Illes-Toth; Christopher J Stubbs; Emma K Sisley; Jeddidiah Bellamy-Carter; Anna L Simmonds; Todd H Mize; Iain B Styles; Richard J A Goodwin; Helen J Cooper
Journal:  J Am Soc Mass Spectrom       Date:  2022-06-08       Impact factor: 3.262

2.  The PyRosetta Toolkit: a graphical user interface for the Rosetta software suite.

Authors:  Jared Adolf-Bryfogle; Roland L Dunbrack
Journal:  PLoS One       Date:  2013-07-09       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.